查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1791224

流動明膠止血劑市場報告：2031 年趨勢、預測與競爭分析

Flowable Gelatin Haemostatic Matrix Market Report: Trends, Forecast and Competitive Analysis to 2031
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球流動明膠止血劑市場前景光明，在神經外科、婦產科、整形外科、一般外科和耳鼻喉科市場都蘊藏著巨大的機會。預計2025年至2031年期間，全球流動明膠止血劑市場的複合年成長率將達到6.7%。該市場的主要驅動力包括：微創手術需求的不斷成長、創傷護理中對有效止血劑的需求日益成長，以及醫療應用中對生物衍生材料的日益偏好。

  • Lucintel 預測，按類型分類，豬明膠預計在預測期內將出現高速成長。
  • 從應用角度來看，普通外科預計將實現最高成長。
  • 按地區分類，預計北美將在預測期內實現最高成長。

透過一份超過 150 頁的綜合報告獲取寶貴的見解，為您的業務決策提供資訊。

流動明膠止血劑市場的新趨勢

流動明膠止血劑市場受到各種新興趨勢的影響，旨在最大限度地提高止血功效、最佳化操作性能並擴大臨床應用。

  • 與活性止血劑合併使用以提高療效：另一個重要趨勢是將流動明膠止血劑與凝血酶、纖維蛋白原和氧化纖維素等活性止血劑聯合使用，旨在產生協同作用，從而更快、更有效的止血，特別是在困難出血的情況下。
  • 設計易於使用的產品：設計無需復溶或配製的即用型流動明膠止血劑正日益受到重視。此類配方提高了便利性，減少了手術室操作時間，並降低了配製錯誤的風險。
  • 與抗菌劑聯合使用，最大程度降低感染風險：目前，抗菌劑與流動明膠止血劑聯合使用已成為一種新趨勢，旨在同時達到止血效果並最大程度降低手術部位感染的風險，這是術後護理的關鍵問題。
  • 提高生物分解性和組織整合性：目前正在進行研究，以最大程度地提高流動明膠止血劑的生物分解性，確保其完全吸收，不會留下可能阻礙癒合或引起副作用的殘留物。增強組織整合性也是一項主要目標。
  • 注射和靶向輸送系統的開發：注射和靶向輸送系統的開發代表著一種日益成長的趨勢，即製造可流動的明膠止血劑，可以以微創的方式輸送，或使用專門的施用器或導管標靶化到特定的出血部位，從而進一步增加其在腹腔鏡和內視鏡手術中的應用。

這些趨勢正在改變流動明膠止血劑市場，推動創新，開發止血性能更佳、使用更便利、感染風險更低、且適用於多種外科專業的產品。對聯合治療、即用型、抗菌活性、最佳化的生物分解性和先進輸送系統的重視，正在推動改善手術效果和保護患者。

流動明膠止血劑市場的最新趨勢

流動明膠止血劑產業的特點是不斷研究，旨在最大限度地提高材料性能及其在手術室中的應用。

  • 先進的明膠加工製程：一項關鍵的進步是明膠加工製程的改進，從而生產出粒徑、孔隙率和膨脹能力最大化的止血劑。這些改進增加了血小板黏附和聚集的表面積，從而實現更有效的止血。
  • 交聯明膠止血劑的開發：人們也在研究明膠分子的交聯，以提高流動止血劑材料的機械強度和抗劣化能力，從而實現更持久的止血效果，特別是在高流量出血情況下。
  • 整合成像劑以實現術中可視化：一家公司正在探索將成像劑加入可流動明膠止血劑中，以使用類似於螢光成像的方法改善所應用材料的術中可視化。
  • 製造具有可控膨脹特性的止血鉗：流動明膠止血鉗的最大膨脹能力必須得到控制，以促進傷口癒合，同時避免對鄰近組織造成過大壓力。目前，技術進步正在實現可控膨脹或預先編程膨脹。
  • 引入符合人體工學的精確輸送系統：各公司正在努力開發易於使用的輸送系統，包括帶有細預填充的預填充施用器，以便將流體明膠止血劑精確且可控地應用於出血部位，即使在難以觸及的區域。

這些進步顯著影響了流動明膠止血劑市場，為外科醫生提供了更有效率、更靈活、更便利的工具，以實現快速、一致的止血。目前，人們專注於明膠特性的最佳化、交聯、術中可視化、可控制腫脹和標靶輸送，以改善手術效果和病患安全。

目錄

第1章執行摘要

第2章 市場概述

  • 背景和分類
  • 供應鏈

第3章：市場趨勢與預測分析

  • 宏觀經濟趨勢與預測
  • 產業驅動力與挑戰
  • PESTLE分析
  • 專利分析
  • 法規環境

第4章 全球流動明膠止血劑市場（按類型）

  • 概述
  • 按類型進行吸引力分析
  • 豬明膠：趨勢與預測（2019-2031）
  • 牛明膠：趨勢與預測（2019-2031）

第5章 全球流動明膠止血劑市場（按應用）

  • 概述
  • 按用途進行吸引力分析
  • 神經外科：趨勢與預測（2019-2031）
  • 婦產科：趨勢與預測（2019-2031）
  • 整形外科：趨勢與預測（2019-2031）
  • 一般外科：趨勢與預測（2019-2031）
  • 耳鼻喉科：趨勢與預測（2019-2031）
  • 其他：趨勢與預測（2019-2031）

第6章區域分析

  • 概述
  • 全球流動明膠止血劑市場（按地區）

第7章北美流動明膠止血劑市場

  • 概述
  • 北美流動明膠止血劑市場（按類型）
  • 北美流動明膠止血劑市場（按應用）
  • 美國流動明膠止血劑市場
  • 墨西哥流動明膠止血劑市場
  • 加拿大流動明膠止血劑市場

第8章歐洲流動明膠止血劑市場

  • 概述
  • 歐洲流動明膠止血劑市場類型
  • 歐洲流動明膠止血劑市場（按應用）
  • 德國流動明膠止血劑市場
  • 法國流動明膠止血劑市場
  • 西班牙流動明膠止血劑市場
  • 義大利流動明膠止血劑市場
  • 英國流動明膠止血劑市場

第9章 亞太地區流動明膠止血劑市場

  • 概述
  • 亞太流動明膠止血劑市場（按類型）
  • 亞太流動明膠止血劑市場（按應用）
  • 日本流動明膠止血劑市場
  • 印度流動明膠止血劑市場
  • 中國流動明膠止血劑市場
  • 韓國液體明膠止血劑市場
  • 印尼流動明膠止血劑市場

第10章世界其他地區流動明膠止血劑市場

  • 概述
  • 世界其他地區流動明膠止血劑市場（按類型）
  • 世界其他地區流動明膠止血劑市場（按應用）
  • 中東流動明膠止血劑市場
  • 南美洲流動明膠止血劑市場
  • 非洲流動明膠止血劑市場

第11章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析
    • 競爭對手之間的競爭
    • 買方的議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 新進入者的威脅
  • 市場佔有率分析

第12章機會與策略分析

  • 價值鏈分析
  • 成長機會分析
    • 按類型分類的成長機會
    • 按應用分類的成長機會
  • 全球流動明膠止血劑市場的新趨勢
  • 戰略分析
    • 新產品開發
    • 認證和許可
    • 合併、收購、協議、合作和合資企業

第13章：價值鏈主要企業的公司簡介

  • 競爭分析
  • Ferrosan Medical Devices
  • Baxter
  • Aegis Lifesciences
  • Pfizer
  • Jiangxi Boenrui
  • Beijing Nashi Biosurgery
  • Shenzhen HUANOVA

第14章 附錄

  • List of Figures
  • List of Tables
  • Research Methodology
  • Disclaimer
  • Copyright
  • Abbreviations and Technical Units
  • About Us
  • Contact Us

The future of the global flowable gelatin haemostatic matrix market looks promising with opportunities in the neurosurgery, obstetrics & gynecology, orthopedic, general surgery, and otolaryngology markets. The global flowable gelatin haemostatic matrix market is expected to grow with a CAGR of 6.7% from 2025 to 2031. The major drivers for this market are the rising demand for minimally invasive surgeries, the growing need for effective hemostatic agents in trauma care, and the increasing preference for biologically-derived materials in medical applications.

  • Lucintel forecasts that, within the type category, porcine gelatin is expected to witness higher growth over the forecast period.
  • Within the application category, general surgery is expected to witness the highest growth.
  • In terms of region, North America is expected to witness the highest growth over the forecast period.

Gain valuable insights for your business decisions with our comprehensive 150+ page report. Sample figures with some insights are shown below.

Emerging Trends in the Flowable Gelatin Haemostatic Matrix Market

The flowable gelatin haemostatic matrix market is influenced by various emerging trends that are aimed at maximizing their haemostatic effectiveness, optimizing their handling characteristics, and extending their clinical applications.

  • Combination with Active Hemostatic Agents to Improve Efficacy: Another important trend involves the combination of flowable gelatin matrices with active haemostatic agents including thrombin, fibrinogen, or oxidized cellulose. These are designed to impart synergistic action, resulting in more rapid and effective hemostasis, especially in difficult bleeding situations.
  • Design of Ready-to-Use Products for Easy Application: An increased emphasis exists on designing ready-to-use flowable gelatin haemostatic matrices that make reconstitution or preparation unnecessary. Such formulations enhance convenience, shorten operating room time, and lower the potential for preparation mistakes.
  • Combination with Antimicrobial Agents to Minimize Infection Risk: A new trend is the combination of antimicrobial agents with flowable gelatin haemostatic matrices. This is intended to offer hemostasis while also minimizing the risk of surgical site infection, an important issue in postoperative management.
  • Biodegradability and Tissue Integration Improvements: Research is aimed at maximizing the biodegradability of flowable gelatin matrices to allow full absorption without residual material that might hinder healing or induce adverse reactions. Enhanced tissue integration is also a primary target.
  • Injectable and Targeted Delivery System Development: Development of injectable and targeted delivery systems is a growing trend towards creating flowable gelatin haemostatic matrices that are deliverable by minimally invasive methods or targeted to the specific sites of bleeding using special applicators or catheters, further increasing their use in laparoscopic and endoscopic surgery.

These trends are transforming the flowable gelatin haemostatic matrix market by propelling innovation towards products with greater haemostatic performance, better convenience, lower risk of infection, and broader applicability to multiple surgical specialties. The emphasis on combination therapy, ready-to-use presentation, antimicrobial activity, biodegradability optimization, and sophisticated delivery systems is directed at enhancing surgical results and patient protection.

Recent Developments in the Flowable Gelatin Haemostatic Matrix Market

The flowable gelatin haemostatic matrix industry is marked by continuous research aimed at maximizing the material properties and usage in operating rooms.

  • Advanced Gelatin Processing Methods: One of the important advancements is improvements in the processing of gelatin to produce matrices with maximum particle size, porosity, and swelling capacity. Such refinement results in increased surface area for platelet adhesion and aggregation, thus providing more efficient hemostasis.
  • Cross-Linked Gelatin Matrix Development: Cross-linking of gelatin molecules is also being investigated to improve the mechanical strength and resistance to degradation of flowable haemostatic matrices. This has the potential to deliver more sustained hemostasis, especially in high-flow bleeding.
  • Imaging Agent Integration for Intraoperative Visualization: Certain companies are exploring the integration of imaging agents into flowable gelatin haemostatic matrices to enable improved intraoperative visualization of the material applied using methods such as fluorescence imaging.
  • Production of Matrices with Regulated Swelling Character: The ability of flowable gelatin haemostatic matrices to swell to a maximum requires regulation so as not to build up too much pressure on contiguous tissues while facilitating sealing of wounds. Advances address controlled and pre-programmed swelling.
  • Introduction of Ergonomic and Accurate Delivery Systems: Companies are working towards the development of easy-to-use delivery systems, including pre-filled applicators with fine tips, enabling accurate and controlled application of the flowable gelatin matrix at the site of bleeding, even in hard-to-reach locations.

These advancements are profoundly affecting the flowable gelatin haemostatic matrix market by offering surgeons more efficient, versatile, and convenient instruments for rapid and consistent hemostasis. The emphasis on optimized gelatin characteristics, cross-linking, intraoperative visualization, controlled swelling, and targeted delivery leads to enhanced surgical outcomes and patient safety.

Strategic Growth Opportunities in the Flowable Gelatin Haemostatic Matrix Market

The flowable gelatin haemostatic matrix market provides some strategic growth opportunities through many of the major surgical applications.

  • Cardiovascular Surgery: The requirement for efficient and biocompatible haemostatic agents in complicated cardiovascular procedures, such as cardiac and vascular surgeries, is a strong growth opportunity for flowable gelatin haemostatic matrices, especially those with active agents.
  • Orthopedic Surgery: Maintenance of hemostasis in orthopedic operations, particularly during large joint arthroplasties and spine surgery, is important. The flowable gelatin matrices have a useful place in controlling oozing hemorrhage in such situations and pose a large growing opportunity.
  • Neurosurgery: Hemostasis in refined neurosurgical interventions demands highly biocompatible materials with favorable application ease. Flowable gelatin matrices pose an effective, safe solution to haemostatic bleeding control within the central nervous system, identifying a major opportunity for growth.
  • General Surgery and Trauma: The wide variety of general surgical procedures and trauma cases commonly present with major bleeding. Flowable gelatin haemostatic matrices offer a general-purpose solution to achieve hemostasis quickly in these varied situations, offering a huge growth opportunity.
  • Minimally Invasive Surgery (MIS): Growing use of MIS technologies, including laparoscopy and endoscopy, generates a need for haemostatic products that will be easily delivered via small incisions or endoluminal lumen. Flowable gelatin matrices with sophisticated delivery systems are particularly suited for these uses, providing a major opportunity for growth.

Seizing these strategic growth opportunities necessitates that manufacturers create flowable gelatin haemostatic matrices that are customized to meet the unique demands of each surgical specialty. This involves optimizing the formulation, delivery system, and performance characteristics to meet the distinct challenges and needs of cardiovascular, orthopedic, neurosurgical, general, trauma, and minimally invasive surgeries.

Flowable Gelatin Haemostatic Matrix Market Driver and Challenges

The market for flowable gelatin haemostatic matrices is driven by a mix of factors that promote its use and pose some challenges to its growth and development.

The factors responsible for driving the flowable gelatin haemostatic matrix market include:

1. Growing Number of Surgical Procedures: The growing number of surgical procedures being conducted worldwide, fueled by an aging population and improved surgical techniques, directly boosts the demand for effective haemostatic agents such as flowable gelatin matrices.

2. Increasing Demand for Advanced Hemostatic Products: Surgeons are increasingly demanding advanced haemostatic products that provide quick, consistent, and biocompatible bleeding control over conventional techniques, fueling the use of flowable gelatin matrices.

3. Multifaceted Use Across Different Surgical Specialties: The versatility of flowable gelatin haemostatic matrices in being used across a wide variety of surgical specialties such as cardiovascular, orthopedic, neurosurgery, and general surgery supports their high market demand.

4. Friendly Biocompatibility and Safety Profile: Gelatin is a biocompatible and natural material with an established safety profile, and flowable gelatin matrices are hence a popular choice among surgeons worried about tissue reaction and long-term consequences.

5. Sustained Product Development and Innovation: Active development and research activities aimed at improving the efficacy, workability, and use of flowable gelatin matrices are resulting in better products and increasing their clinical applications.

Challenges in the flowable gelatin haemostatic matrix market are:

1. Competition from Other Advanced Hemostatic Agents: The market for flowable gelatin haemostatic matrices is competitively challenged by other advanced haemostatic products, including oxidized regenerated cellulose, collagen hemostats, and synthetic sealants, which can provide various benefits in certain surgical contexts.

2. Cost Considerations in Healthcare Systems: The price of advanced haemostatic agents, such as flowable gelatin matrices, can be a major determinant, especially in cost-sensitive markets or in those healthcare systems with limited budgets.

3. Proper Training and Usage Protocols: Proper training of surgical personnel on preparation and application methods is crucial for the successful application of flowable gelatin haemostatic matrices to achieve optimal hemostasis with minimal complications.

The rising number of surgical procedures, the increased demand for sophisticated haemostatic products, and the versatility and beneficial biocompatibility of flowable gelatin matrices are prime drivers behind the expansion of this market. Continuous product development further adds to their attractiveness. Nevertheless, competition from other haemostatic agents, economic factors, and the requirement for adequate training create challenges that need to be met by manufacturers and healthcare professionals in order to provide continued and universal acceptance of flowable gelatin haemostatic matrices in surgery.

List of Flowable Gelatin Haemostatic Matrix Companies

  • Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, flowable gelatin haemostatic matrix companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the flowable gelatin haemostatic matrix companies profiled in this report include:
  • Ferrosan Medical Devices
  • Baxter
  • Aegis Lifesciences
  • Pfizer
  • Jiangxi Boenrui
  • Beijing Nashi Biosurgery
  • Shenzhen HUANOVA

Flowable Gelatin Haemostatic Matrix Market by Segment

The study includes a forecast for the global flowable gelatin haemostatic matrix market by type, application, and region.

Flowable Gelatin Haemostatic Matrix Market by Type [Value from 2019 to 2031]:

  • Porcine Gelatin
  • Bovine Gelatin

Flowable Gelatin Haemostatic Matrix Market by Application [Value from 2019 to 2031]:

  • Neurosurgery
  • Obstetrics & Gynecology
  • Orthopedics
  • General Surgery
  • Otolaryngology
  • Others

Flowable Gelatin Haemostatic Matrix Market by Region [Value from 2019 to 2031]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the Flowable Gelatin Haemostatic Matrix Market

The flowable gelatin haemostatic matrix market industry is a major area of surgical hemostasis, providing a biocompatible and efficient option for the management of bleeding in a variety of surgical applications. Recent trends throughout the United States, China, Germany, India, and Japan represent a worldwide tendency towards increased efficacy, greater ease of handling, and increased usage. Gelatin processing innovations, the addition of adjunctive haemostatic agents, and developments in delivery systems are primary areas of interest. Market forces are also driven by the expanding number of surgical procedures and the growing need for advanced haemostatic products with fast and consistent bleeding control.

  • United States: The American market is noted for having a high rate of adoption of state-of-the-art haemostatic technologies and strong product innovation. Some of the recent advances have been the launch of flowable gelatin matrices with improved swelling ability for greater wound sealing and the addition of thrombin or other clotting factors to speed up hemostasis. An emphasis has also been placed on creating products that are simple to prepare and use in a wide range of surgery.
  • China: The Chinese market is seeing tremendous growth in the medical device market, including haemostatic devices. Recent news includes the expanding domestic production of flowable gelatin matrices, frequently at lower prices. In addition, there is a focus on enhancing the quality and effectiveness of these locally produced products to address the needs of a fast-growing healthcare system.
  • Germany: Highly technologically advanced in medicine, Germany has a trend in advanced flowable gelatin haemostatic matrices with defined performance attributes and biocompatibility. Some of the recent advancements include gelatin particle size and distribution optimization for increased surface area and clotting rate. User-friendly packaging and delivery forms as well as exact application are also emphasized.
  • India: The Indian market is experiencing growing acceptance of newer surgical techniques and rising demand for efficient haemostatic agents. Recent trends have been the increasing availability of flowable gelatin matrices from both domestic and foreign suppliers. Increasing emphasis is also being placed on cost-effective products that offer consistent hemostasis in a variety of surgical specialties.
  • Japan: Japan's market is focusing on high-quality and safety considerations in medical devices. Some new developments include introducing flowable gelatin haemostatic matrices that have improved biodegradability and low tissue reaction. Also emphasized are products that provide immediate and sustained hemostasis to lead to enhanced surgical outcomes as well as minimized postoperative complications.

Features of the Global Flowable Gelatin Haemostatic Matrix Market

  • Market Size Estimates: Flowable gelatin haemostatic matrix market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
  • Segmentation Analysis: Flowable gelatin haemostatic matrix market size by type, application, and region in terms of value ($B).
  • Regional Analysis: Flowable gelatin haemostatic matrix market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the flowable gelatin haemostatic matrix market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the flowable gelatin haemostatic matrix market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers the following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the flowable gelatin haemostatic matrix market by type (porcine gelatin and bovine gelatin), application (neurosurgery, obstetrics & gynecology, orthopedics, general surgery, otolaryngology, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

  • 2.1 Background and Classifications
  • 2.2 Supply Chain

3. Market Trends & Forecast Analysis

  • 3.1 Macroeconomic Trends and Forecasts
  • 3.2 Industry Drivers and Challenges
  • 3.3 PESTLE Analysis
  • 3.4 Patent Analysis
  • 3.5 Regulatory Environment

4. Global Flowable Gelatin Haemostatic Matrix Market by Type

  • 4.1 Overview
  • 4.2 Attractiveness Analysis by Type
  • 4.3 Porcine Gelatin: Trends and Forecast (2019-2031)
  • 4.4 Bovine Gelatin: Trends and Forecast (2019-2031)

5. Global Flowable Gelatin Haemostatic Matrix Market by Application

  • 5.1 Overview
  • 5.2 Attractiveness Analysis by Application
  • 5.3 Neurosurgery: Trends and Forecast (2019-2031)
  • 5.4 Obstetrics & Gynecology: Trends and Forecast (2019-2031)
  • 5.5 Orthopedics: Trends and Forecast (2019-2031)
  • 5.6 General Surgery: Trends and Forecast (2019-2031)
  • 5.7 Otolaryngology: Trends and Forecast (2019-2031)
  • 5.8 Others: Trends and Forecast (2019-2031)

6. Regional Analysis

  • 6.1 Overview
  • 6.2 Global Flowable Gelatin Haemostatic Matrix Market by Region

7. North American Flowable Gelatin Haemostatic Matrix Market

  • 7.1 Overview
  • 7.2 North American Flowable Gelatin Haemostatic Matrix Market by Type
  • 7.3 North American Flowable Gelatin Haemostatic Matrix Market by Application
  • 7.4 United States Flowable Gelatin Haemostatic Matrix Market
  • 7.5 Mexican Flowable Gelatin Haemostatic Matrix Market
  • 7.6 Canadian Flowable Gelatin Haemostatic Matrix Market

8. European Flowable Gelatin Haemostatic Matrix Market

  • 8.1 Overview
  • 8.2 European Flowable Gelatin Haemostatic Matrix Market by Type
  • 8.3 European Flowable Gelatin Haemostatic Matrix Market by Application
  • 8.4 German Flowable Gelatin Haemostatic Matrix Market
  • 8.5 French Flowable Gelatin Haemostatic Matrix Market
  • 8.6 Spanish Flowable Gelatin Haemostatic Matrix Market
  • 8.7 Italian Flowable Gelatin Haemostatic Matrix Market
  • 8.8 United Kingdom Flowable Gelatin Haemostatic Matrix Market

9. APAC Flowable Gelatin Haemostatic Matrix Market

  • 9.1 Overview
  • 9.2 APAC Flowable Gelatin Haemostatic Matrix Market by Type
  • 9.3 APAC Flowable Gelatin Haemostatic Matrix Market by Application
  • 9.4 Japanese Flowable Gelatin Haemostatic Matrix Market
  • 9.5 Indian Flowable Gelatin Haemostatic Matrix Market
  • 9.6 Chinese Flowable Gelatin Haemostatic Matrix Market
  • 9.7 South Korean Flowable Gelatin Haemostatic Matrix Market
  • 9.8 Indonesian Flowable Gelatin Haemostatic Matrix Market

10. ROW Flowable Gelatin Haemostatic Matrix Market

  • 10.1 Overview
  • 10.2 ROW Flowable Gelatin Haemostatic Matrix Market by Type
  • 10.3 ROW Flowable Gelatin Haemostatic Matrix Market by Application
  • 10.4 Middle Eastern Flowable Gelatin Haemostatic Matrix Market
  • 10.5 South American Flowable Gelatin Haemostatic Matrix Market
  • 10.6 African Flowable Gelatin Haemostatic Matrix Market

11. Competitor Analysis

  • 11.1 Product Portfolio Analysis
  • 11.2 Operational Integration
  • 11.3 Porter's Five Forces Analysis
    • Competitive Rivalry
    • Bargaining Power of Buyers
    • Bargaining Power of Suppliers
    • Threat of Substitutes
    • Threat of New Entrants
  • 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

  • 12.1 Value Chain Analysis
  • 12.2 Growth Opportunity Analysis
    • 12.2.1 Growth Opportunities by Type
    • 12.2.2 Growth Opportunities by Application
  • 12.3 Emerging Trends in the Global Flowable Gelatin Haemostatic Matrix Market
  • 12.4 Strategic Analysis
    • 12.4.1 New Product Development
    • 12.4.2 Certification and Licensing
    • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

  • 13.1 Competitive Analysis
  • 13.2 Ferrosan Medical Devices
    • Company Overview
    • Flowable Gelatin Haemostatic Matrix Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.3 Baxter
    • Company Overview
    • Flowable Gelatin Haemostatic Matrix Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.4 Aegis Lifesciences
    • Company Overview
    • Flowable Gelatin Haemostatic Matrix Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.5 Pfizer
    • Company Overview
    • Flowable Gelatin Haemostatic Matrix Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.6 Jiangxi Boenrui
    • Company Overview
    • Flowable Gelatin Haemostatic Matrix Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.7 Beijing Nashi Biosurgery
    • Company Overview
    • Flowable Gelatin Haemostatic Matrix Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.8 Shenzhen HUANOVA
    • Company Overview
    • Flowable Gelatin Haemostatic Matrix Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing

14. Appendix

  • 14.1 List of Figures
  • 14.2 List of Tables
  • 14.3 Research Methodology
  • 14.4 Disclaimer
  • 14.5 Copyright
  • 14.6 Abbreviations and Technical Units
  • 14.7 About Us
  • 14.8 Contact Us

List of Figures

  • Figure 1.1: Trends and Forecast for the Global Flowable Gelatin Haemostatic Matrix Market
  • Figure 2.1: Usage of Flowable Gelatin Haemostatic Matrix Market
  • Figure 2.2: Classification of the Global Flowable Gelatin Haemostatic Matrix Market
  • Figure 2.3: Supply Chain of the Global Flowable Gelatin Haemostatic Matrix Market
  • Figure 2.4: Driver and Challenges of the Flowable Gelatin Haemostatic Matrix Market
  • Figure 3.1: Trends of the Global GDP Growth Rate
  • Figure 3.2: Trends of the Global Population Growth Rate
  • Figure 3.3: Trends of the Global Inflation Rate
  • Figure 3.4: Trends of the Global Unemployment Rate
  • Figure 3.5: Trends of the Regional GDP Growth Rate
  • Figure 3.6: Trends of the Regional Population Growth Rate
  • Figure 3.7: Trends of the Regional Inflation Rate
  • Figure 3.8: Trends of the Regional Unemployment Rate
  • Figure 3.9: Trends of Regional Per Capita Income
  • Figure 3.10: Forecast for the Global GDP Growth Rate
  • Figure 3.11: Forecast for the Global Population Growth Rate
  • Figure 3.12: Forecast for the Global Inflation Rate
  • Figure 3.13: Forecast for the Global Unemployment Rate
  • Figure 3.14: Forecast for the Regional GDP Growth Rate
  • Figure 3.15: Forecast for the Regional Population Growth Rate
  • Figure 3.16: Forecast for the Regional Inflation Rate
  • Figure 3.17: Forecast for the Regional Unemployment Rate
  • Figure 3.18: Forecast for Regional Per Capita Income
  • Figure 4.1: Global Flowable Gelatin Haemostatic Matrix Market by Type in 2019, 2024, and 2031
  • Figure 4.2: Trends of the Global Flowable Gelatin Haemostatic Matrix Market ($B) by Type
  • Figure 4.3: Forecast for the Global Flowable Gelatin Haemostatic Matrix Market ($B) by Type
  • Figure 4.4: Trends and Forecast for Porcine Gelatin in the Global Flowable Gelatin Haemostatic Matrix Market (2019-2031)
  • Figure 4.5: Trends and Forecast for Bovine Gelatin in the Global Flowable Gelatin Haemostatic Matrix Market (2019-2031)
  • Figure 5.1: Global Flowable Gelatin Haemostatic Matrix Market by Application in 2019, 2024, and 2031
  • Figure 5.2: Trends of the Global Flowable Gelatin Haemostatic Matrix Market ($B) by Application
  • Figure 5.3: Forecast for the Global Flowable Gelatin Haemostatic Matrix Market ($B) by Application
  • Figure 5.4: Trends and Forecast for Neurosurgery in the Global Flowable Gelatin Haemostatic Matrix Market (2019-2031)
  • Figure 5.5: Trends and Forecast for Obstetrics & Gynecology in the Global Flowable Gelatin Haemostatic Matrix Market (2019-2031)
  • Figure 5.6: Trends and Forecast for Orthopedics in the Global Flowable Gelatin Haemostatic Matrix Market (2019-2031)
  • Figure 5.7: Trends and Forecast for General Surgery in the Global Flowable Gelatin Haemostatic Matrix Market (2019-2031)
  • Figure 5.8: Trends and Forecast for Otolaryngology in the Global Flowable Gelatin Haemostatic Matrix Market (2019-2031)
  • Figure 5.9: Trends and Forecast for Others in the Global Flowable Gelatin Haemostatic Matrix Market (2019-2031)
  • Figure 6.1: Trends of the Global Flowable Gelatin Haemostatic Matrix Market ($B) by Region (2019-2024)
  • Figure 6.2: Forecast for the Global Flowable Gelatin Haemostatic Matrix Market ($B) by Region (2025-2031)
  • Figure 7.1: Trends and Forecast for the North American Flowable Gelatin Haemostatic Matrix Market (2019-2031)
  • Figure 7.2: North American Flowable Gelatin Haemostatic Matrix Market by Type in 2019, 2024, and 2031
  • Figure 7.3: Trends of the North American Flowable Gelatin Haemostatic Matrix Market ($B) by Type (2019-2024)
  • Figure 7.4: Forecast for the North American Flowable Gelatin Haemostatic Matrix Market ($B) by Type (2025-2031)
  • Figure 7.5: North American Flowable Gelatin Haemostatic Matrix Market by Application in 2019, 2024, and 2031
  • Figure 7.6: Trends of the North American Flowable Gelatin Haemostatic Matrix Market ($B) by Application (2019-2024)
  • Figure 7.7: Forecast for the North American Flowable Gelatin Haemostatic Matrix Market ($B) by Application (2025-2031)
  • Figure 7.8: Trends and Forecast for the United States Flowable Gelatin Haemostatic Matrix Market ($B) (2019-2031)
  • Figure 7.9: Trends and Forecast for the Mexican Flowable Gelatin Haemostatic Matrix Market ($B) (2019-2031)
  • Figure 7.10: Trends and Forecast for the Canadian Flowable Gelatin Haemostatic Matrix Market ($B) (2019-2031)
  • Figure 8.1: Trends and Forecast for the European Flowable Gelatin Haemostatic Matrix Market (2019-2031)
  • Figure 8.2: European Flowable Gelatin Haemostatic Matrix Market by Type in 2019, 2024, and 2031
  • Figure 8.3: Trends of the European Flowable Gelatin Haemostatic Matrix Market ($B) by Type (2019-2024)
  • Figure 8.4: Forecast for the European Flowable Gelatin Haemostatic Matrix Market ($B) by Type (2025-2031)
  • Figure 8.5: European Flowable Gelatin Haemostatic Matrix Market by Application in 2019, 2024, and 2031
  • Figure 8.6: Trends of the European Flowable Gelatin Haemostatic Matrix Market ($B) by Application (2019-2024)
  • Figure 8.7: Forecast for the European Flowable Gelatin Haemostatic Matrix Market ($B) by Application (2025-2031)
  • Figure 8.8: Trends and Forecast for the German Flowable Gelatin Haemostatic Matrix Market ($B) (2019-2031)
  • Figure 8.9: Trends and Forecast for the French Flowable Gelatin Haemostatic Matrix Market ($B) (2019-2031)
  • Figure 8.10: Trends and Forecast for the Spanish Flowable Gelatin Haemostatic Matrix Market ($B) (2019-2031)
  • Figure 8.11: Trends and Forecast for the Italian Flowable Gelatin Haemostatic Matrix Market ($B) (2019-2031)
  • Figure 8.12: Trends and Forecast for the United Kingdom Flowable Gelatin Haemostatic Matrix Market ($B) (2019-2031)
  • Figure 9.1: Trends and Forecast for the APAC Flowable Gelatin Haemostatic Matrix Market (2019-2031)
  • Figure 9.2: APAC Flowable Gelatin Haemostatic Matrix Market by Type in 2019, 2024, and 2031
  • Figure 9.3: Trends of the APAC Flowable Gelatin Haemostatic Matrix Market ($B) by Type (2019-2024)
  • Figure 9.4: Forecast for the APAC Flowable Gelatin Haemostatic Matrix Market ($B) by Type (2025-2031)
  • Figure 9.5: APAC Flowable Gelatin Haemostatic Matrix Market by Application in 2019, 2024, and 2031
  • Figure 9.6: Trends of the APAC Flowable Gelatin Haemostatic Matrix Market ($B) by Application (2019-2024)
  • Figure 9.7: Forecast for the APAC Flowable Gelatin Haemostatic Matrix Market ($B) by Application (2025-2031)
  • Figure 9.8: Trends and Forecast for the Japanese Flowable Gelatin Haemostatic Matrix Market ($B) (2019-2031)
  • Figure 9.9: Trends and Forecast for the Indian Flowable Gelatin Haemostatic Matrix Market ($B) (2019-2031)
  • Figure 9.10: Trends and Forecast for the Chinese Flowable Gelatin Haemostatic Matrix Market ($B) (2019-2031)
  • Figure 9.11: Trends and Forecast for the South Korean Flowable Gelatin Haemostatic Matrix Market ($B) (2019-2031)
  • Figure 9.12: Trends and Forecast for the Indonesian Flowable Gelatin Haemostatic Matrix Market ($B) (2019-2031)
  • Figure 10.1: Trends and Forecast for the ROW Flowable Gelatin Haemostatic Matrix Market (2019-2031)
  • Figure 10.2: ROW Flowable Gelatin Haemostatic Matrix Market by Type in 2019, 2024, and 2031
  • Figure 10.3: Trends of the ROW Flowable Gelatin Haemostatic Matrix Market ($B) by Type (2019-2024)
  • Figure 10.4: Forecast for the ROW Flowable Gelatin Haemostatic Matrix Market ($B) by Type (2025-2031)
  • Figure 10.5: ROW Flowable Gelatin Haemostatic Matrix Market by Application in 2019, 2024, and 2031
  • Figure 10.6: Trends of the ROW Flowable Gelatin Haemostatic Matrix Market ($B) by Application (2019-2024)
  • Figure 10.7: Forecast for the ROW Flowable Gelatin Haemostatic Matrix Market ($B) by Application (2025-2031)
  • Figure 10.8: Trends and Forecast for the Middle Eastern Flowable Gelatin Haemostatic Matrix Market ($B) (2019-2031)
  • Figure 10.9: Trends and Forecast for the South American Flowable Gelatin Haemostatic Matrix Market ($B) (2019-2031)
  • Figure 10.10: Trends and Forecast for the African Flowable Gelatin Haemostatic Matrix Market ($B) (2019-2031)
  • Figure 11.1: Porter's Five Forces Analysis of the Global Flowable Gelatin Haemostatic Matrix Market
  • Figure 11.2: Market Share (%) of Top Players in the Global Flowable Gelatin Haemostatic Matrix Market (2024)
  • Figure 12.1: Growth Opportunities for the Global Flowable Gelatin Haemostatic Matrix Market by Type
  • Figure 12.2: Growth Opportunities for the Global Flowable Gelatin Haemostatic Matrix Market by Application
  • Figure 12.3: Growth Opportunities for the Global Flowable Gelatin Haemostatic Matrix Market by Region
  • Figure 12.4: Emerging Trends in the Global Flowable Gelatin Haemostatic Matrix Market

List of Tables

  • Table 1.1: Growth Rate (%, 2023-2024) and CAGR (%, 2025-2031) of the Flowable Gelatin Haemostatic Matrix Market by Type and Application
  • Table 1.2: Attractiveness Analysis for the Flowable Gelatin Haemostatic Matrix Market by Region
  • Table 1.3: Global Flowable Gelatin Haemostatic Matrix Market Parameters and Attributes
  • Table 3.1: Trends of the Global Flowable Gelatin Haemostatic Matrix Market (2019-2024)
  • Table 3.2: Forecast for the Global Flowable Gelatin Haemostatic Matrix Market (2025-2031)
  • Table 4.1: Attractiveness Analysis for the Global Flowable Gelatin Haemostatic Matrix Market by Type
  • Table 4.2: Market Size and CAGR of Various Type in the Global Flowable Gelatin Haemostatic Matrix Market (2019-2024)
  • Table 4.3: Market Size and CAGR of Various Type in the Global Flowable Gelatin Haemostatic Matrix Market (2025-2031)
  • Table 4.4: Trends of Porcine Gelatin in the Global Flowable Gelatin Haemostatic Matrix Market (2019-2024)
  • Table 4.5: Forecast for Porcine Gelatin in the Global Flowable Gelatin Haemostatic Matrix Market (2025-2031)
  • Table 4.6: Trends of Bovine Gelatin in the Global Flowable Gelatin Haemostatic Matrix Market (2019-2024)
  • Table 4.7: Forecast for Bovine Gelatin in the Global Flowable Gelatin Haemostatic Matrix Market (2025-2031)
  • Table 5.1: Attractiveness Analysis for the Global Flowable Gelatin Haemostatic Matrix Market by Application
  • Table 5.2: Market Size and CAGR of Various Application in the Global Flowable Gelatin Haemostatic Matrix Market (2019-2024)
  • Table 5.3: Market Size and CAGR of Various Application in the Global Flowable Gelatin Haemostatic Matrix Market (2025-2031)
  • Table 5.4: Trends of Neurosurgery in the Global Flowable Gelatin Haemostatic Matrix Market (2019-2024)
  • Table 5.5: Forecast for Neurosurgery in the Global Flowable Gelatin Haemostatic Matrix Market (2025-2031)
  • Table 5.6: Trends of Obstetrics & Gynecology in the Global Flowable Gelatin Haemostatic Matrix Market (2019-2024)
  • Table 5.7: Forecast for Obstetrics & Gynecology in the Global Flowable Gelatin Haemostatic Matrix Market (2025-2031)
  • Table 5.8: Trends of Orthopedics in the Global Flowable Gelatin Haemostatic Matrix Market (2019-2024)
  • Table 5.9: Forecast for Orthopedics in the Global Flowable Gelatin Haemostatic Matrix Market (2025-2031)
  • Table 5.10: Trends of General Surgery in the Global Flowable Gelatin Haemostatic Matrix Market (2019-2024)
  • Table 5.11: Forecast for General Surgery in the Global Flowable Gelatin Haemostatic Matrix Market (2025-2031)
  • Table 5.12: Trends of Otolaryngology in the Global Flowable Gelatin Haemostatic Matrix Market (2019-2024)
  • Table 5.13: Forecast for Otolaryngology in the Global Flowable Gelatin Haemostatic Matrix Market (2025-2031)
  • Table 5.14: Trends of Others in the Global Flowable Gelatin Haemostatic Matrix Market (2019-2024)
  • Table 5.15: Forecast for Others in the Global Flowable Gelatin Haemostatic Matrix Market (2025-2031)
  • Table 6.1: Market Size and CAGR of Various Regions in the Global Flowable Gelatin Haemostatic Matrix Market (2019-2024)
  • Table 6.2: Market Size and CAGR of Various Regions in the Global Flowable Gelatin Haemostatic Matrix Market (2025-2031)
  • Table 7.1: Trends of the North American Flowable Gelatin Haemostatic Matrix Market (2019-2024)
  • Table 7.2: Forecast for the North American Flowable Gelatin Haemostatic Matrix Market (2025-2031)
  • Table 7.3: Market Size and CAGR of Various Type in the North American Flowable Gelatin Haemostatic Matrix Market (2019-2024)
  • Table 7.4: Market Size and CAGR of Various Type in the North American Flowable Gelatin Haemostatic Matrix Market (2025-2031)
  • Table 7.5: Market Size and CAGR of Various Application in the North American Flowable Gelatin Haemostatic Matrix Market (2019-2024)
  • Table 7.6: Market Size and CAGR of Various Application in the North American Flowable Gelatin Haemostatic Matrix Market (2025-2031)
  • Table 7.7: Trends and Forecast for the United States Flowable Gelatin Haemostatic Matrix Market (2019-2031)
  • Table 7.8: Trends and Forecast for the Mexican Flowable Gelatin Haemostatic Matrix Market (2019-2031)
  • Table 7.9: Trends and Forecast for the Canadian Flowable Gelatin Haemostatic Matrix Market (2019-2031)
  • Table 8.1: Trends of the European Flowable Gelatin Haemostatic Matrix Market (2019-2024)
  • Table 8.2: Forecast for the European Flowable Gelatin Haemostatic Matrix Market (2025-2031)
  • Table 8.3: Market Size and CAGR of Various Type in the European Flowable Gelatin Haemostatic Matrix Market (2019-2024)
  • Table 8.4: Market Size and CAGR of Various Type in the European Flowable Gelatin Haemostatic Matrix Market (2025-2031)
  • Table 8.5: Market Size and CAGR of Various Application in the European Flowable Gelatin Haemostatic Matrix Market (2019-2024)
  • Table 8.6: Market Size and CAGR of Various Application in the European Flowable Gelatin Haemostatic Matrix Market (2025-2031)
  • Table 8.7: Trends and Forecast for the German Flowable Gelatin Haemostatic Matrix Market (2019-2031)
  • Table 8.8: Trends and Forecast for the French Flowable Gelatin Haemostatic Matrix Market (2019-2031)
  • Table 8.9: Trends and Forecast for the Spanish Flowable Gelatin Haemostatic Matrix Market (2019-2031)
  • Table 8.10: Trends and Forecast for the Italian Flowable Gelatin Haemostatic Matrix Market (2019-2031)
  • Table 8.11: Trends and Forecast for the United Kingdom Flowable Gelatin Haemostatic Matrix Market (2019-2031)
  • Table 9.1: Trends of the APAC Flowable Gelatin Haemostatic Matrix Market (2019-2024)
  • Table 9.2: Forecast for the APAC Flowable Gelatin Haemostatic Matrix Market (2025-2031)
  • Table 9.3: Market Size and CAGR of Various Type in the APAC Flowable Gelatin Haemostatic Matrix Market (2019-2024)
  • Table 9.4: Market Size and CAGR of Various Type in the APAC Flowable Gelatin Haemostatic Matrix Market (2025-2031)
  • Table 9.5: Market Size and CAGR of Various Application in the APAC Flowable Gelatin Haemostatic Matrix Market (2019-2024)
  • Table 9.6: Market Size and CAGR of Various Application in the APAC Flowable Gelatin Haemostatic Matrix Market (2025-2031)
  • Table 9.7: Trends and Forecast for the Japanese Flowable Gelatin Haemostatic Matrix Market (2019-2031)
  • Table 9.8: Trends and Forecast for the Indian Flowable Gelatin Haemostatic Matrix Market (2019-2031)
  • Table 9.9: Trends and Forecast for the Chinese Flowable Gelatin Haemostatic Matrix Market (2019-2031)
  • Table 9.10: Trends and Forecast for the South Korean Flowable Gelatin Haemostatic Matrix Market (2019-2031)
  • Table 9.11: Trends and Forecast for the Indonesian Flowable Gelatin Haemostatic Matrix Market (2019-2031)
  • Table 10.1: Trends of the ROW Flowable Gelatin Haemostatic Matrix Market (2019-2024)
  • Table 10.2: Forecast for the ROW Flowable Gelatin Haemostatic Matrix Market (2025-2031)
  • Table 10.3: Market Size and CAGR of Various Type in the ROW Flowable Gelatin Haemostatic Matrix Market (2019-2024)
  • Table 10.4: Market Size and CAGR of Various Type in the ROW Flowable Gelatin Haemostatic Matrix Market (2025-2031)
  • Table 10.5: Market Size and CAGR of Various Application in the ROW Flowable Gelatin Haemostatic Matrix Market (2019-2024)
  • Table 10.6: Market Size and CAGR of Various Application in the ROW Flowable Gelatin Haemostatic Matrix Market (2025-2031)
  • Table 10.7: Trends and Forecast for the Middle Eastern Flowable Gelatin Haemostatic Matrix Market (2019-2031)
  • Table 10.8: Trends and Forecast for the South American Flowable Gelatin Haemostatic Matrix Market (2019-2031)
  • Table 10.9: Trends and Forecast for the African Flowable Gelatin Haemostatic Matrix Market (2019-2031)
  • Table 11.1: Product Mapping of Flowable Gelatin Haemostatic Matrix Suppliers Based on Segments
  • Table 11.2: Operational Integration of Flowable Gelatin Haemostatic Matrix Manufacturers
  • Table 11.3: Rankings of Suppliers Based on Flowable Gelatin Haemostatic Matrix Revenue
  • Table 12.1: New Product Launches by Major Flowable Gelatin Haemostatic Matrix Producers (2019-2024)
  • Table 12.2: Certification Acquired by Major Competitor in the Global Flowable Gelatin Haemostatic Matrix Market